Funding
Current Research Funding
Canadian Institutes for Health Research Foundation grant
July 2019 – June 2026, $5.78 million
Multiple Sclerosis Society of Canada
Hierarchy of inhibitors in the lesion microenvironment for remyelination: combining a novel CNS-targeting therapeutic with exercise to promote repair, 2019-2022, $415,613 over 3 years
Multiple Sclerosis Society of Canada
Elevated axonal and myelin injury with aging: Mechanisms, prevention and prospective therapeutics for progressive multiple sclerosis, 2018- 2021, $420,140 over 3 years
International CoEN initiative in neurodegeneration
With Bertrand Huard, France (The French National Research Agency), CSPG targeting for lesion regeneration in multiple sclerosis, CIHR support of $200,000, Feb 2020 – Jan 2022
Canadian Cancer Society
Unexpected expression of PD1 on brain tumour-initiating cells: a novel regulator of glioblastoma growth, $200,000, November 2020- October 2022